Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 10/20 | 0.38 |
| ▸ | LMNA | P02545 | 7/20 | 0.38 |
| ▸ | HTT | P42858 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 5/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19139674 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL18506694 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL18506656 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL18506667 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL16204303 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL16204299 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL22210771 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL21573718 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL22210756 | 1.00 | ALOX5 (0.46) | ALOX5PTGS1PTGS2RXFP1RAB9A | |
| SCHEMBL12251825 | 0.97 | ALOX5 (0.42) | ALOX5PTGS1PTGS2RXFP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714692-B2 | Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer | LG CHEM, LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170117491-A1 | LIGHT EMITTING DEVICE AND COMPOSITION USED IN THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-27 | — | — | US | disclosed |
| EP-3131131-A1 | LIGHT-EMISSION ELEMENT, AND COMPOSITION USED THEREIN | Sumitomo Chemical Company Limited (JP) | 2017-02-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170117491-A1 | LIGHT EMITTING DEVICE AND COMPOSITION USED IN THE SAME | CYBA, CRY1, AP2A1 | ALOX5 2670/4885PTGS1 1221/4885PTGS2 1669/4885 |
| US-10714692-B2 | Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer | COMT, MAOB, MAOA | ALOX5 1811/4885PTGS1 4247/4885PTGS2 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.